文献库搜索 | GeneLibs

Li(C),Yin(J),Abel(ML),Vargas Solivan(DS),B... NPJ Precis Oncol 2026-04-09

...BRCA2 as potential drivers. These alterations were clonally concordant with circulating tumor DNA from the donor. Pathwa...

Shin(SH),Ahn(SG),Ryu(JM),Lee(SB),Park(HS),... Breast Cancer Res 2026-04-09

...BRCA2 carriers (P = 0.07). Correspondence analysis revealed that, in younger patients (< 50 years) with BRCA1 mutations,...

Odebiyi(OF),Kehinde(A),Abdulsalami(MS),Dib... J Public Health Afr None

...BRCA2. This study investigated the prevalence of SNPs in the TP53 and BRCA2 genes and their association with cervical an...

Sakai(H),Kusumoto-Matsuo(R),Hosonaga(M),No... Breast Cancer 2026-05-00

...BRCA2 mutation. In one patient, BRCA2 reversion mutations were found in ctDNA seven months before radiological confirmat...

Monda(SM),Oh(E),Lewicki(PJ),Kaffenberger(S... Eur Urol Open Sci 2026-04-00

...BRCA2, among others) variants, comparing with an institutional cohort of MMR carriers (n = 35; 2012-2025). We also asses...

Patel(M),Jyotishi(C),Prajapati(S),Gupta(R) Genet Test Mol Biomarkers 2026-05-00

...BRCA2), aligning with increased loss of heterozygosity and exon mutational burden. In addition, Alu hypomethylation furt...

Marek-Yagel(D),Greenberg(R),Naftali(M),Ben... J Mol Diagn 2026-06-00

...BRCA2, and PALB2, whereas LDLR and TPM1 remained largely unchanged. No consistent correlation was found between the exte...

Wakerell(S),Karlsson(Q),Merson(S),Rageevak... Genome Med 2026-04-18

...BRCA2 (1.3%) and 46.0% of study participants had a PRS in the top quintile of the risk distribution. Univariate analyses...

Munir(A),Rizwan(M),Janbey(A) Curr Drug Targets 2026-04-15

...BRCA2, BARD1, PALB2, TP53, CHEK2). Lipid-based nanoparticles (LNPs) and polymeric nanoparticles (PNPs) were developed an...

Nagano(H),Kiyama(S),Kyutoku(T),Matsumoto(H... Otolaryngol Pol 2026-03-19

...BRCA2</i> (16.9%), <i>SPEN</i> (16.9%), with 17.1 7.2 (mean standard error of the mean [SEM]) mutation...